GentiBio Employee Directory
Biotechnology ResearchMassachusetts, United States11-50 Employees
GentiBio is a biotechnology research company based in Cambridge, Massachusetts, focused on developing engineered regulatory T cells to treat immune-related diseases. Founded by leaders in regulatory T cell biology and synthetic immunology, the company operates at an early stage and pursues a platform that supports both autologous and allogeneic EngTregs to restore immune tolerance and address limitations of existing regulatory T-cell therapies. Its work targets autoimmune, alloimmune, autoinflammatory, and allergic conditions, highlighting a cellular-therapy approach at the intersection of immune modulation and disease treatment. The firm aims to serve researchers and clinicians seeking new cell-based options for immune-mediated diseases, as well as potential partners in the biopharma ecosystem. In April 2026, it announced collaborations with NetworxHealth, Seattle Children's Research Institute, and the Benaroya Research Institute to advance its GNTI-122 program and the POLARIS Phase 1 trial in adults recently diagnosed with Type 1 diabetes.